Press release
Why Attend the EuroPotent Therapeutics Summit?
On 22nd-23rd May 2025, Frankfurt, Germany, will host the EuroPotent Therapeutics Summit, organized by Veridon Global-a premier event for professionals in the pharmaceutical and biotech industries focused on high-potency active pharmaceutical ingredients (HPAPI). This summit is a must-attend for those seeking to stay at the forefront of industry innovation and regulation.Key reasons to join include:
• Expert Insights: Gain knowledge from global leaders on regulatory compliance, advanced containment strategies, and safety protocols.
• Cutting-Edge Technologies: Discover the latest digital tools and innovations in HPAPI manufacturing, including machine learning, automation, and process analytical technology (PAT).
• Networking Opportunities: Connect with top-tier professionals, including regulatory affairs experts, production managers, and R&D leaders, to forge valuable collaborations.
• Practical Learning: Participate in workshops and panel discussions to gain actionable strategies for tackling HPAPI production challenges.
• Strategic Focus: Stay ahead in a competitive market by addressing critical issues like supply chain resilience, workforce safety, and environmental sustainability.
Register Now at https://veridonglobal.com/events/europotent-therapeutics-summit/
Whether you're a regulatory affairs specialist, a production engineer, or a pharmaceutical executive, this summit offers unparalleled value. Mark your calendar for 22nd-23rd May 2025 and join us in Frankfurt to shape the future of potent therapeutics.
info@veridonglobal.com
At Veridon Global, we are at the forefront of organizing leading healthcare and life science conferences that inspire progress and innovation. Our events are the go-to platform for decision-makers, industry experts, and pioneers to collaborate on solutions that address global challenges and foster sustainable growth in healthcare.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why Attend the EuroPotent Therapeutics Summit? here
News-ID: 3786787 • Views: …